3,100 results · 19ms · Sources: EU EUDAMED, US FDA

Cap, Cervical, Contraceptive

FDA Pre-Market Approval
FDA Class 3 ·FEM CAP

Intraocular Lens

FDA Pre-Market Approval
FDA Class 3 ·COLLAMER UV-ABSORBING POSTERIOR CHAMBER IOL

Intraocular Lens

FDA Pre-Market Approval
FDA Class 3 ·SILICON UV-ABSORBING POSTERIOR CHAMBER IOL

Catheter, Coronary, Atherectomy

FDA Pre-Market Approval
FDA Class 3 ·IVT CORONARY ATHERECTOMY SYSTEM (TEC)(R)

Catheter, Coronary, Atherectomy

FDA Pre-Market Approval
FDA Class 3 ·IVT CORONARY ATHERECTOMY SYSTEM (TEC)(R)

Catheter, Coronary, Atherectomy

FDA Pre-Market Approval
FDA Class 3 ·IVT CORONARY ATHERECTOMY SYSTEM (TEC)(R)

Catheter, Coronary, Atherectomy

FDA Pre-Market Approval
FDA Class 3 ·IVT CORONARY ATHERECTOMY SYSTEM (TEC)(R)

Catheter, Coronary, Atherectomy

FDA Pre-Market Approval
FDA Class 3 ·IVT CORONARY ATHERECTOMY SYSTEM (TEC)(R)

Catheter, Coronary, Atherectomy

FDA Pre-Market Approval
FDA Class 3 ·IVT CORONARY ATHERECTOMY SYSTEM (TEC)(R)

Implantable Cardioverter Defibrillator (Non-Crt)

FDA Pre-Market Approval
FDA Class 3 ·Telemetry Wand

Acid, Hyaluronic, Intraarticular

FDA Pre-Market Approval
FDA Class 3 ·EUFLEXXA (1% SODIUM HYALURONATE)

Acid, Hyaluronic, Intraarticular

FDA Pre-Market Approval
FDA Class 3 ·EUFLEXXA (1% Sodium Hyaluronate)

Acid, Hyaluronic, Intraarticular

FDA Pre-Market Approval
FDA Class 3 ·EUFLEXXA

Acid, Hyaluronic, Intraarticular

FDA Pre-Market Approval
FDA Class 3 ·EUFLEXXA 1% SODIUM HYALURONATE

Acid, Hyaluronic, Intraarticular

FDA Pre-Market Approval
FDA Class 3 ·Euflexxa (1% Sodium Hyaluronate)

Acid, Hyaluronic, Intraarticular

FDA Pre-Market Approval
FDA Class 3 ·EUFLEXXA

Acid, Hyaluronic, Intraarticular

FDA Pre-Market Approval
FDA Class 3 ·EUFLEXXA (1% SODIUM HYALURONATE)

Acid, Hyaluronic, Intraarticular

FDA Pre-Market Approval
FDA Class 3 ·EUFLEXXA

Acid, Hyaluronic, Intraarticular

FDA Pre-Market Approval
FDA Class 3 ·EUFLEXXA (1% SODIUM HYALURONATE)

Acid, Hyaluronic, Intraarticular

FDA Pre-Market Approval
FDA Class 3 ·EUFLEXXA